Opis działalności
Gedeon Richter Plc., headquartered in Budapest/Hungary, is a major pharmaceutical company in Central Eastern Europe, with an expanding direct presence in Western Europe. The product portfolio of Richter covers almost all important therapeutic areas, including gynaecology, central nervous system, and cardiovascular areas. Having the largest R&D unit in Central Eastern Europe, Richter's original research activity focuses on CNS disorders. With its widely acknowledged steroid chemistry expertise, Richter is a significant player in the female healthcare field worldwide. Richter is also active in biosimilar product development.
Zarząd & Rada nadzorcza
| CEO |
| Gabor Orban |
| Zarząd |
| István Hamecz, Katalin Erdei, Dr István Greiner, Tibor Horváth, Attila Szénási, Tamás Szolyák |
| Rada nadzorcza |
| Prof Dr Szilveszter E. Vizi, Dr Ilona Hardy dr Pintérné, Erik Bogsch, Gábor Orbán, Dr Nándor Pál Ács, Gabriella Balogh, István Hamecz, Dr Péter Cserháti, Mrs Lászlóné Németh, Dr Anett Pandurics, Bálint Szécsényi, Balázs Szepesi, Dr Attila Chikán, Dr Róbert Jonathán Bedros, Dr Krisztina Gál, Dr Zoltán Matos, Dr Lívia Pavlik, Ferenc Sallai |
Dane firmy
| Nazwa: |
Chemical Works of Gedeon Richter PLC |
| Adres: |
Gyömroi út 19-21.,HU-1103 Budapest |
| Telefon: |
+(36) 1-431-4000 |
| Fax: |
+(36) 1-260-6650 |
| E-mail: |
investor.relations@richter.hu
|
| Internet: |
https://www.gedeonrichter.com/en/ |
| Przemysł: |
Służba zdrowia |
| Sektor: |
Przemysł Farmaceutyczny |
| Podsektor: |
- |
| Koniec roku finansowego: |
31.12 |
| Free float: |
74,93% |
| Data IPO: |
09.11.1994 |
